Back to the main directory
EarningsReview / Equity
- XXL Asa - Sell/NOK 5: No improvement in sight by Nordea
- Nobia (Hold, TP: SEK29.00) - Headwinds building by DnB Markets
- Vitrolife (Buy, TP: SEK410.00) - Strong quarter by DnB Markets
- Bravida (Buy, TP: SEK125.00) - High acquisition pace by DnB Markets
- Nordea (Buy, TP: SEK130.00) - NII growth set to accelerate by DnB Markets
- Balder (Hold, TP: SEK60.00) - ‘Hibernation mode’ activated by DnB Markets
- AAK Minor model adjustments by DnB Markets
- Newmont Corporation - A high-dividend safe haven by Edison Investment Research
- Pebble Group - Strong H122 lifts full-year prospects by Edison Investment Research
- Hindustan Unilever Ltd (HUVR IN) by HSBC
- Tele2 (TEL2B SS) by HSBC
- A quarterly binge by BNP Paribas Exane
- Underwhelming update but expectations now rebased by BNP Paribas Exane
- Q2 beats but energy prices drive production cuts by BNP Paribas Exane
- Death by a thousand cuts by BNP Paribas Exane
- INVEST SECURITIES - ALSTOM : Cap maintenu dans un contexte plus compliqué - ACHAT, OC 30,5€ (vs 32,6€) by Invest Securities
- ASML HOLDING NV: RDOS. 2T’22 (ANÁLISIS BANCO SABADELL) by Sabadell
- Itaú BBA on WEG: Flat Figures QoQ in 2Q22 by Itau
- FX, scope, and consensus by BNP Paribas Exane
- Rallis India (RALI IN) by HSBC
- Wavering on both fronts by BNP Paribas Exane
- Still not out of the woods by BNP Paribas Exane
- Bavarian Nordic - Booking orders for the longer term by Danske Bank Equity Research
- Terveystalo - It may get worse before it gets better by Danske Bank Equity Research
- Assa Abloy - Steady as she goes by Danske Bank Equity Research
- Alimak (Hold, TP: SEK85.00) - Strong H2e, but softer beyond by DnB Markets
- Sandvik (Buy, TP: SEK220.00) - No slowdown in demand, yet by DnB Markets
- Enea (Hold, TP: SEK100.00) - Hard reset by DnB Markets
- Scandic Hotels (Buy, TP: SEK61.00) - Record-high performance in Q2 by DnB Markets
- Alligo (Buy, TP: SEK165.00) - ‘Historic Monday’ went well by DnB Markets
- Elisa (Hold, TP: EUR56.00) - Cost increase offsets revenue trend by DnB Markets
- 1Spatial - Flying high with a major EU aerospace company by Edison Investment Research
- Oryzon Genomics - CRADA win to provide a halo effect by Edison Investment Research
- Sequana Medical - A step closer on DSR heart failure programme by Edison Investment Research
- Victrex Plc (VCT LN) by HSBC
- Hard times for hardlines, but what''s priced in? by BNP Paribas Exane
- Consistency, a much-underrated quality by BNP Paribas Exane
- Not immune, but Azure is the antidote by BNP Paribas Exane
- No quick fix by BNP Paribas Exane
- Investment Daily 20/07/2022 by BNP Paribas Exane
- VIDRALA: RDOS. 2T’22 (ANÁLISIS BANCO SABADELL) by Sabadell
- VIDRALA: 2Q’22 RESULTS (ANÁLISIS BANCO SABADELL) by Sabadell
- Q2 22: a strong step in the right direction by BNP Paribas Exane
- How long until affordability declines? by BNP Paribas Exane
- Wipro (WPRO IN) by HSBC
- IndusInd Bank (IIB IN) by HSBC
- A step in the right direction by BNP Paribas Exane
- AAK - Handling the choppy waters well; reiterate Buy by Danske Bank Equity Research
- Atlas Copco - Profitability not compressed by Danske Bank Equity Research
- BHG Group - Defending profitability better than feared by Danske Bank Equity Research